Clinical Trials Logo

Hemangioma clinical trials

View clinical trials related to Hemangioma.

Filter by:

NCT ID: NCT03209804 Completed - Clinical trials for Intracranial Arteriovenous Malformations

Surgical Management of Cerebral Arteriovenous Malformations Within Hybrid Operation Room

SMAVMHR
Start date: June 2016
Phase: N/A
Study type: Interventional

To evaluate the clinical benefits and risks of hybrid operating techniques in management of cerebral arteriovenous malformations.

NCT ID: NCT03169595 Completed - Clinical trials for Epithelioid Hemangioma of Bone

Epithelioid Hemangioma of Bone And Soft Tissue

EE-META
Start date: October 7, 2015
Phase: N/A
Study type: Observational

The controversy surrounding epithelioid hemangioma diagnosis stems from its somewhat aggressive clinical characteristics, including multifocal presentation and occasional lymph node involvement. The investigators reviewed the clinicopathologic and radiologic characteristics of bone and soft tissue epithelioid hemangioma in patients treated at our institution with available tissue for molecular testing. The hypothesis is that epithelioid hemangioma may present with multifocal involvement and rare loco-regional lymph node metastasis, but it remains a benign tumor with excellent prognosis.

NCT ID: NCT02913612 Completed - Clinical trials for Infantile Hemangioma

Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH)

TIM01
Start date: May 5, 2017
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the safety and efficacy of Timolol 0.25% and 0.5% doses.

NCT ID: NCT02755467 Completed - Spider Angioma Clinical Trials

Clinical Evaluation of the Treatment of Spider Angioma

Start date: May 26, 2016
Phase: N/A
Study type: Interventional

To evaluate the safety and effectiveness of the laser treatment for the treatment of spider angiomas.

NCT ID: NCT02731287 Completed - Hemangioma Clinical Trials

Topical Timolol for Infantile Hemangioma in Early Proliferative Phase

Start date: March 2014
Phase: Phase 2
Study type: Interventional

Infantile hemangioma (IH) is the most common benign vascular tumor in pediatric population. Oral propranolol is the treatment of choice for complicated hemangiomas. Topical timolol, a non-selective beta-blocker, is an emerging treatment which has been reported to be effective and safe for the treatment of IH, especially for superficial hemangiomas. Investigators hypothesize that treatment with topical timolol in the first two months of life, before the proliferative phase or in early proliferative phase, may prevent from further growing and the need to treat with oral propranolol.

NCT ID: NCT02602990 Completed - Clinical trials for Cerebral Arteriovenous Malformations

Treatment of Cerebral Arteriovenous Malformations With SQUID™ Liquid Embolic Agent

Start date: August 2015
Phase:
Study type: Observational [Patient Registry]

A non-interventional multicentric study for patients with a cerebral AVM for which endovascular treatment is indicated.

NCT ID: NCT02576535 Completed - Clinical trials for Intracranial Arteriovenous Malformations (AVM)

Protocol for Staged Stereotactic Radiosurgery for Large Arteriovenous Malformations

Start date: February 2000
Phase: N/A
Study type: Interventional

Stereotactic radiosurgery is a well established treatment option for arteriovenous malformations (AVMs). The potential complications related to radiosurgery are well documented and are predominately related to radiation effects to the surrounding brain parenchyma. These risks increase with larger lesions, requiring a concommitant reduction in the amount of radiation that can be delivered. This reduction in radiation dose decreases the efficacy of treatment. The broad, long-term objectives of this proposal are 1) to determine the role of fractionated stereotactic radiosurgery in the treatment of large (>10cc) AVMs; 2) to evaluate the complication rates related to fractionating these doses compared to conventional stereotactic treatment 3) to evaluate the success rate of treating large AVMs with this protocol.

NCT ID: NCT02505971 Completed - Clinical trials for Infantile Hemangioma

Nadolol Versus Propranolol in Children With Infantile Hemangiomas

Start date: September 2015
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the efficacy and safety of oral propranolol versus nadolol in patients with Infantile Hemangiomas (IH) in a randomized, controlled, double-blinded study.

NCT ID: NCT02436213 Completed - Clinical trials for Hereditary Hemorrhagic Telangiectasia

Cardiopulmonary Exercise Testing to Evaluate Pulmonary AVMs

Start date: April 2011
Phase: N/A
Study type: Interventional

Pulmonary arteriovenous malformations (PAVMs) are a rare vascular condition affecting the lungs. PAVMs lead to low blood oxygen levels, yet are very well tolerated by patients. This study will examine the exercise capacity of PAVM patients using formal cardiopulmonary exercise tests performed on a stationary bicycle.

NCT ID: NCT02378883 Completed - Clinical trials for Arteriovenous Malformations

Apollo™ Onyx™ Delivery Microcatheter Post Market Safety Study

Start date: May 18, 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the safety of the Apollo™ Onyx™ Delivery Microcatheter used for delivery of the Onyx™ Liquid Embolic System during brain arteriovenous malformation (AVM) embolization procedures.